Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine: Sachets containing oral powder 27 g, 30; Sachets containing oral powder 35 g, 30; PKU Sphere® 15, PKU Sphere® 20

Page last updated: 27 October 2017

• Public Summary Document (PSD) July 2017 PBAC Meeting - (PDF 178 KB)
• Public Summary Document (PSD) July 2017 PBAC Meeting - (Word 50 KB)